The Beneficial Effects of a Multispecies Probiotic Supplement on Glycaemic Control and Metabolic Profile in Adults with Type 1 Diabetes: A Randomised, Double-Blinded, Placebo-Controlled Pilot-Study

References

• Expert Committee on the D, Classification of Diabetes M. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5–20. doi:10.2337/diacare.26.2007.s5
   PubMed Web of Science ®Google Scholar
• Lipman TH, Levitt Katz LE, Ratcliffe SJ, et al. Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia pediatric diabetes registry. Diabetes Care. 2013;36(6):1597–1603. doi:10.2337/dc12-0767
   PubMed Web of Science ®Google Scholar
• Paun A, Yau C, Danska JS. Immune recognition and response to the intestinal microbiome in type 1 diabetes. J Autoimmun. 2016;71:10–18. doi:10.1016/j.jaut.2016.02.004
   PubMed Web of Science ®Google Scholar
• Vatanen T, Franzosa EA, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562(7728):589–594. doi:10.1038/s41586-018-0620-2
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11:46. doi:10.1186/1741-7015-11-46
   PubMed Web of Science ®Google Scholar
• Harbison JE, Roth-Schulze AJ, Giles LC, et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study. Pediatr Diabetes. 2019;20(5):574–583. doi:10.1111/pedi.12865
   PubMed Web of Science ®Google Scholar
• Kim SH, Huh CS, Choi ID, et al. The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo. J Appl Microbiol. 2014;117(3):834–845. doi:10.1111/jam.12573
   PubMed Web of Science ®Google Scholar
• Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One. 2010;5(5):e10507. doi:10.1371/journal.pone.0010507
   PubMed Web of Science ®Google Scholar
• Rittiphairoj T, Pongpirul K, Janchot K, Mueller NT, Li T. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Adv Nutr. 2021;12(3):722–734. doi:10.1093/advances/nmaa133
   PubMed Web of Science ®Google Scholar
• Zare Javid A, Aminzadeh M, Haghighi-Zadeh MH, Jamalvandi M. The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 Diabetic Patients. A placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab Syndr Obes. 2020;13:607–617. doi:10.2147/DMSO.S238867
   PubMed Web of Science ®Google Scholar
• Maiorino MI, Signoriello S, Maio A, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146–1156. doi:10.2337/dc19-1459
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu D, Xu P, et al. Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial. Endocr Connect. 2021;10(9):1045–1054. doi:10.1530/EC-21-0146
   PubMed Web of Science ®Google Scholar
• Uusitalo U, Liu X, Yang J, et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY study. JAMA Pediatr. 2016;170(1):20–28. doi:10.1001/jamapediatrics.2015.2757
   PubMed Web of Science ®Google Scholar
• Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem. 2013;288(35):25088–25097. doi:10.1074/jbc.M113.452516
   PubMed Web of Science ®Google Scholar
• Toshimitsu T, Gotou A, Sashihara T, et al. Effects of 12-week ingestion of yogurt containing lactobacillus plantarum OLL2712 on glucose metabolism and chronic inflammation in prediabetic adults: a randomized placebo-controlled trial. Nutrients. 2020;12(2). doi:10.3390/nu12020374
   PubMed Web of Science ®Google Scholar
• Sabico S, Al-Mashharawi A, Al-Daghri NM, et al. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(4):1561–156910. doi:10.1016/j.clnu.2018.08.009
   PubMed Web of Science ®Google Scholar
• Bock PM, Telo GH, Ramalho R, et al. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetologia. 2021;64(1):26–41. doi:10.1007/s00125-020-05295-1
   PubMed Web of Science ®Google Scholar
• Aila JA, Valma H, Carol F, Riitta F, Sari M, Groop PH. The self-reported use of probiotics is associated with better glycaemic control and lower odds of metabolic syndrome and its components in type 1 diabetes. J Probiotics Health. 2017;5(4). doi:10.4172/2329-8901.1000188
   PubMedGoogle Scholar
• Firouzi S, Majid HA, Ismail A, Kamaruddin NA, Barakatun-Nisak MY. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur J Nutr. 2017;56(4):1535–1550. doi:10.1007/s00394-016-1199-8
   PubMed Web of Science ®Google Scholar
• Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: a randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabetes. 2021;22(7):1014–1022. doi:10.1111/pedi.13244
   PubMed Web of Science ®Google Scholar
• Sargsyan A, Herman MA. Regulation of glucose production in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2019;19(9):77. doi:10.1007/s11892-019-1195-5
   PubMed Web of Science ®Google Scholar
• Sondertoft NB, Vogt JK, Arumugam M, et al. The intestinal microbiome is a co-determinant of the postprandial plasma glucose response. PLoS One. 2020;15(9):e0238648. doi:10.1371/journal.pone.0238648
   PubMed Web of Science ®Google Scholar
• Oh MR, Jang HY, Lee SY, et al. Lactobacillus plantarum HAC01 supplementation improves glycemic control in prediabetic subjects: a randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13(7):2337. doi:10.3390/nu13072337
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374–2383. doi:10.1007/s00125-007-0791-0
   PubMed Web of Science ®Google Scholar
• Roager HM, Hansen LB, Bahl MI, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016;1(9):16093. PMID: 27562254. doi:10.1038/nmicrobiol.2016.93
   PubMed Web of Science ®Google Scholar
• Wilmot EG, Choudhary P, Leelarathna L, Baxter M. Glycaemic variability: the under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes Metab. 2019;21(12):2599–2608. doi:10.1111/dom.13842
   PubMed Web of Science ®Google Scholar
• Lu J, Home PD, Zhou J. Comparison of multiple cut points for time in range in relation to risk of abnormal carotid intima-media thickness and diabetic retinopathy. Diabetes Care. 2020;43(8):e99–e101. doi:10.2337/dc20-0561
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhong H, Li Y, Shi Z, Ren H, Ji L. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities. Nat Aging. 2021;1(1):87–100. doi:10.1038/s43587-020-00014-2
   PubMedGoogle Scholar
• Zhang X, Wang D, Zheng Y, et al. Sex-dependent effects on the gut microbiota and host metabolome in type 1 diabetic mice. Biochim Biophys Acta Mol Basis Dis. 2021;1867(12):166266. doi:10.1016/j.bbadis.2021.166266
   PubMed Web of Science ®Google Scholar
• Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787–8803. doi:10.3748/wjg.v21.i29.8787
   PubMed Web of Science ®Google Scholar
• Dong Y, Xu M, Chen L, Bhochhibhoya A. Probiotic foods and supplements interventions for metabolic syndromes: a systematic review and meta-analysis of recent clinical trials. Ann Nutr Metab. 2019;74(3):224–241. doi:10.1159/000499028
   PubMed Web of Science ®Google Scholar
• Zarezadeh M, Musazadeh V, Faghfouri AH, Roshanravan N, Dehghan P. Probiotics act as a potent intervention in improving lipid profile: an umbrella systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;1–14. doi:10.1080/10408398.2021.2004578
   Google Scholar
• Reis SA, Conceicao LL, Rosa DD, Siqueira NP, Peluzio MCG. Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics. Nutr Res Rev. 2017;30(1):36–49. doi:10.1017/S0954422416000226
   PubMed Web of Science ®Google Scholar
• Raygan F, Rezavandi Z, Bahmani F, et al. The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease. Diabetol Metab Syndr. 2018;10:51. doi:10.1186/s13098-018-0353-2
   PubMed Web of Science ®Google Scholar
• Raygan F, Ostadmohammadi V, Asemi Z. The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(4):1594–1598. doi:10.1016/j.clnu.2018.07.017
   PubMed Web of Science ®Google Scholar
• Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. doi:10.2337/dci19-0028
   PubMed Web of Science ®Google Scholar